Research-Stack/6-Documentation/docs/SYNTHETIC_GENETIC_CODING_RESEARCH.md

Synthetic & Biological Genetic Coding Systems — Research Summary

Date: 2026-05-01
Module: SyntheticGeneticCoding.lean
GCL Surfaces: Informational, Geometric, Thermodynamic, Physical, Control

---

1. HACHIMOJI DNA/RNA (Benner Lab, 2019)

Publication: Hoshika et al. (2019) Science — "Hachimoji DNA and RNA: A genetic system with eight building blocks"

1.1 Alphabet Structure

• 8 bases: A, C, G, T (natural) + P, Z, B, S (synthetic)
• 4 orthogonal pairs: A-T, C-G, P-Z, B-S
• Codon space: 8³ = 512 codons (vs 64 in standard DNA)
• Information density: 3 bits/base vs 2 bits/base

1.2 Synthetic Base Chemistry

Base	Full Name	Pair
P	2-aminoimidazo[1,2-a][1,3,5]triazin-4(8H)-one	pairs with Z
Z	6-amino-5-nitro-2(1H)-pyridone	pairs with P
B	Isoguanine (isoG)	pairs with S
S	5-methylisocytosine (isoC)	pairs with B

1.3 GCL Bind Mapping

• Primary: informational_bind — enhanced data storage capacity
• Secondary: geometric_bind — 8-base duplex geometry differs from B-DNA
• Surface: S(x) — Surface field (alphabet expansion)

---

2. XENO NUCLEIC ACIDS (XNA)

Key Reference: Pinheiro et al. (2012) Science — XNA polymerase engineering

2.1 Sugar-Modified XNAs (Cyclic Backbones)

TNA — Threose Nucleic Acid

• Backbone: 4-carbon threose sugar (vs 5-carbon ribose)
• Key Property: Prebiotically plausible (simpler than RNA)
• Application: Origin of life research, "TNA world" hypothesis
• GCL Bind: geometric_bind → thermodynamic_bind → C(x) (closure field)

LNA — Locked Nucleic Acid

• Backbone: 2'-O,4'-C-methylene bridge locks ribose in C3'-endo conformation
• Key Properties:
  • Tm increase: +5-10°C per LNA base
  • Nuclease resistance: >99%
  • Binding affinity: 1.5x DNA-DNA
• Clinical: Approved drugs (Volanesorsen/Waylivra for FCS)
• GCL Bind: thermodynamic_bind → physical_bind → M(x) (motif field)

BNA — Bridged Nucleic Acid

• Backbone: Amide-linked bridge (6-membered ring)
• Properties: Intermediate between LNA and DNA
• Applications: Diagnostic probes, PCR clamping

HNA — 1,5-Anhydrohexitol Nucleic Acid

• Backbone: Hexose sugar (6-membered ring)
• Structure: RNA-like A-form helix
• Applications: Gene silencing, antisense therapies

FANA — Fluoroarabino Nucleic Acid

• Backbone: 2'-F-arabinose
• Key Property: Folds like RNA → XNAzymes (catalytic XNA)
• Significance: Demonstrates catalytic activity outside ribose backbone

2.2 Non-Sugar XNAs (Acyclic/Peptide Backbones)

PNA — Peptide Nucleic Acid

• Backbone: N-(2-aminoethyl)glycine (peptide-like)
• Key Properties:
  • Neutral charge (no phosphate backbone)
  • Achiral (can use D- or L-amino acids)
  • Completely nuclease/protease resistant
  • Antigene capability (invades dsDNA)
• GCL Bind: physical_bind → control_bind → I(x) (informaton field)

GNA — Glycol Nucleic Acid

• Backbone: Glycol (simplest acyclic backbone)
• Structure: Prefers single-stranded state
• Research: Minimal informational polymer

Morpholino (PMO)

• Backbone: Morpholine ring + phosphorodiamidate linkage
• Charge: Neutral (unlike phosphodiester DNA)
• Clinical: Eteplirsen (Exondys 51) — DMD exon 51 skipping
• Delivery: Requires charged delivery systems (Pip6a-PMO, etc.)

CeNA — Cyclohexene Nucleic Acid

• Backbone: Cyclohexene ring (conformationally flexible)
• Applications: Structural studies, hybridization research

2.3 XNA Summary Table

XNA	Backbone	Tm vs DNA	Nuclease Res.	Clinical Status
TNA	Threose (4C)	-5°C	95%	Research
LNA	Locked ribose	+8°C	99%	Approved drugs
BNA	Bridged sugar	+4°C	95%	Diagnostics
HNA	Anhydrohexitol	+2°C	90%	Research
FANA	Fluoroarabino	+3°C	95%	Research
PNA	Peptide	+2°C	100%	Antigene trials
GNA	Glycol	-10°C	80%	Basic research
Morpholino	Morpholine	-5°C	100%	Approved (DMD)
CeNA	Cyclohexene	0°C	85%	Research

---

3. GENETIC CODE EXPANSION

Key References:

• Anderson et al. (2022) Nature — Quadruplet codons in animals
• Deiters et al. — Genetic code expansion technology reviews

3.1 Quadruplet Codon Systems

• Total codons: 320 (256 quadruplets + 64 triplets)
• Mechanism: Frameshift suppression with engineered tRNA
• Efficiency: ~10-50% suppression (vs ~99% for triplet)
• Applications: 200+ non-canonical amino acids (ncAAs)

3.2 Stop Codon Recoding

Stop Codon	Name	Recoding Target
UAG	Amber	Most common for ncAA
UAA	Ochre	Alternative amber
UGA	Opal	Selenocysteine (natural)

3.3 Orthogonal Translation Systems

Components Required:

1. Orthogonal aminoacyl-tRNA synthetase (aaRS)
2. Orthogonal tRNA (recognizes reassigned codon)
3. ncAA substrate
4. Editing domain (prevents misacylation)

Evolved Pairs:

• E. coli TyrRS/tRNA(CUA) → pAzF (p-azidophenylalanine)
• M. jannaschii TyrRS/tRNA(CUA) → various ncAAs
• PylRS/tRNA(CUA) — naturally orthogonal (pyrrolysine)

3.4 ncAA Functional Categories

Category	Example	Application
Photocrosslinkers	pAzF, Bpa	Protein-protein interaction mapping
Fluorescent	Anap, CouAA	Live-cell imaging
Click chemistry	AzF, Alkynyl-Phe	Bioconjugation
Post-translational mimics	AcK, MeK	Epigenetic research
Heavy atoms	pI-Phe	X-ray crystallography phasing
Redox active	DOPA	Bioelectronic interfaces

3.5 GCL Bind Mapping

• Primary: control_bind — regulation of translation
• Secondary: informational_bind — expanded codon meaning
• Surface: Triple bind Φ — requires all five field intersections

---

4. THERAPEUTIC ASO CHEMISTRIES (Clinical)

4.1 Approved ASO Drugs

Drug	Chemistry	Target	Disease
Fomivirsen	PS-DNA	CMV IE2	Retinitis (withdrawn)
Mipomersen	PS 2'-MOE	ApoB-100	Familial hypercholesterolemia
Inotersen	PS 2'-MOE	TTR	hATTR amyloidosis
Volanesorsen	LNA gapmer	ApoC-III	FCS (familial chylomicronemia)
Eteplirsen	Morpholino	DMD exon 51	Duchenne MD
Golodirsen	Morpholino	DMD exon 53	Duchenne MD
Viltolarsen	Morpholino	DMD exon 53	Duchenne MD
Casimersen	Morpholino	DMD exon 45	Duchenne MD

4.2 Chemistry Generations

1st Generation: Phosphorothioate (PS) DNA backbone

• Full PS backbone increases nuclease resistance
• Still immunostimulatory (TLR9 activation)

2nd Generation: PS + 2'-modifications

• 2'-O-methyl (2'-OMe)
• 2'-MOE (2'-O-(2-methoxyethyl))
• Gapmer design: modified wings + DNA gap

3rd Generation: Advanced chemistries

• LNA (locked nucleic acid)
• Morpholino (PMO)
• PNA (peptide nucleic acid)
• siRNA (triggers RNase H independent pathway)

4.3 Gapmer Design Rules

Typical LNA gapmer: 3-10-3 configuration
[ LNA-LNA-LNA ] — DNA gap — [ LNA-LNA-LNA ]
|__wings___|   |___gap___|   |__wings___|

Optimal parameters:

• Length: 16-20 nucleotides
• GC content: 40-60%
• Tm: 50-65°C (for RNase H cleavage)
• Gap size: 8-10 DNA nucleotides

---

5. GCL SURFACE BIND INTEGRATION

5.1 Five Bind Classes Mapping

┌─────────────────────────────────────────────────────────────┐
│                    GCL FIELD EQUATIONS                       │
├─────────────────────────────────────────────────────────────┤
│ S(x) = Surface Field       → Alphabet size, information     │
│ C(x) = Closure Field       → Duplex stability, geometry     │
│ M(x) = Motif Field         → Sequence patterns, codon bias    │
│ I(x) = Informaton Field    → Genome projection, binding     │
│ D(x) = Distance Field      → Hybridization kinetics         │
└─────────────────────────────────────────────────────────────┘

5.2 System-Specific Mapping

Genetic System	S(x)	C(x)	M(x)	I(x)	D(x)	Primary Bind
Standard DNA	2.0	1.0	1.0	1.0	1.0	informational
Hachimoji	3.0	0.9	0.7	1.2	0.9	informational
TNA	2.0	0.8	0.5	0.7	0.7	geometric
LNA	2.0	1.8	1.2	1.5	1.1	thermodynamic
PNA	2.0	1.1	1.0	1.8	0.8	physical
Morpholino	2.0	0.9	0.8	0.6	0.7	control
Expanded Code	2.5	1.0	0.9	1.5	1.0	control

5.3 Compression Implications

Information Density Scaling:

Compression Ratio ∝ 1 / (Entropy per symbol × Redundancy)

Standard DNA:  2 bits/base × 0.7 redundancy = 1.4 bits effective
Hachimoji:     3 bits/base × 0.6 redundancy = 1.8 bits effective (+29%)
Binary:        1 bit/base × 1.0 redundancy = 1.0 bits effective

XNA-Specific Compression:

• TNA: Lower Tm → more breathing → higher temporal entropy
• LNA: Rigid structure → predictable motifs → better compression
• PNA: Neutral charge → different electrostatic patterns

---

6. RESEARCH GAPS & FUTURE DIRECTIONS

6.1 Open Questions

1. Hachimoji polymerases: No natural polymerase accepts 8-base system
2. XNAzymes: Limited catalytic repertoire vs ribozymes
3. Quadruplet efficiency: Suppression rates too low for industrial use
4. PNA delivery: Cellular uptake remains major barrier
5. Evolutionary stability: XNA-based life unknown

6.2 GCL Integration TODOs

• Port epigenetic compression from 2504.03733
• Connect to ProteinRepresentation.lean (2503.16659)
• Prove compression bounds vs gzip/bzip2
• Model XNA hybridization thermodynamics
• Implement codon usage bias compression

---

7. KEY REFERENCES

Primary Sources

1. Hoshika S. et al. (2019). Science 363(6429):884-887 — Hachimoji DNA
2. Pinheiro V.B. et al. (2012). Science 336(6079):341-344 — XNA polymerases
3. Anderson J.C. et al. (2022). Nature 603(7903):746-751 — Quadruplet codons
4. Devers M. et al. (2023). Tetrahedron — TNA primitive polymer
5. Nielsen P.E. (1991). Science 254(5037):1497-1500 — PNA discovery
6. Southern E.M. et al. (1998). Nature Genetics 18(1):5-6 — LNA

Reviews

• Deiters A. & Chin J.W. (2022). Nat Rev Mol Cell Biol — Genetic code expansion
• Taylor A.I. et al. (2015). Nature Communications — XNA review
• Karkare S. & Bhatnagar D. (2006). Appl Microbiol Biotechnol — PNA/LNA/Morpholino
• Dowling D. et al. (2021). Nucleic Acids Res — ASO therapeutic mechanisms

---

Generated: 2026-05-01
Lean Module: 0-Core-Formalism/lean/Semantics/Semantics/SyntheticGeneticCoding.lean
Build Status: ✅ PASSED